Presentation is loading. Please wait.

Presentation is loading. Please wait.

414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement    Molecular Therapy 

Similar presentations


Presentation on theme: "414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement    Molecular Therapy "— Presentation transcript:

1 414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement  Molecular Therapy  Volume 22, Pages S158-S159 (May 2014) DOI: /S (16) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

2 Figure 1 A. Wild type dog with normal masticatory muscles; B. Affected dog with temporal (arrows) and masseter muscle atrophy; C. Wild type dog holding the jaw in a closed position; D. Affected dog unable to hold the jaw in a closed position. Molecular Therapy  , S158-S159DOI: ( /S (16) ) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions


Download ppt "414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement    Molecular Therapy "

Similar presentations


Ads by Google